

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.57820653 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.57240447 |
| 3 | DNA deamination (GO:0045006) | 5.18604741 |
| 4 | protein neddylation (GO:0045116) | 5.13835107 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.12349026 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.93168623 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 4.93168623 |
| 8 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.82360069 |
| 9 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.82360069 |
| 10 | NADH dehydrogenase complex assembly (GO:0010257) | 4.82360069 |
| 11 | respiratory electron transport chain (GO:0022904) | 4.58918918 |
| 12 | protein complex biogenesis (GO:0070271) | 4.58632528 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.56917886 |
| 14 | electron transport chain (GO:0022900) | 4.52036313 |
| 15 | maturation of SSU-rRNA (GO:0030490) | 4.46920432 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 4.37082963 |
| 17 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.36110832 |
| 18 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.34182914 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 4.25621495 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.20735658 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.20047968 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 4.18813757 |
| 23 | proteasome assembly (GO:0043248) | 4.16555618 |
| 24 | viral transcription (GO:0019083) | 4.11955294 |
| 25 | DNA strand elongation (GO:0022616) | 4.10572099 |
| 26 | translational termination (GO:0006415) | 4.03795507 |
| 27 | telomere maintenance via recombination (GO:0000722) | 3.95272018 |
| 28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.93214133 |
| 29 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.91382248 |
| 30 | nucleobase biosynthetic process (GO:0046112) | 3.84288778 |
| 31 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.84128364 |
| 32 | DNA replication initiation (GO:0006270) | 3.82998802 |
| 33 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.82519942 |
| 34 | DNA replication checkpoint (GO:0000076) | 3.81714159 |
| 35 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.79987357 |
| 36 | negative regulation of ligase activity (GO:0051352) | 3.79987357 |
| 37 | chaperone-mediated protein transport (GO:0072321) | 3.79687819 |
| 38 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.77598381 |
| 39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.77598381 |
| 40 | ribosomal large subunit biogenesis (GO:0042273) | 3.77314467 |
| 41 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.77015876 |
| 42 | purine nucleobase biosynthetic process (GO:0009113) | 3.76876955 |
| 43 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.75574560 |
| 44 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.75574560 |
| 45 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.75574560 |
| 46 | sequestering of actin monomers (GO:0042989) | 3.74740271 |
| 47 | cotranslational protein targeting to membrane (GO:0006613) | 3.70133519 |
| 48 | translational elongation (GO:0006414) | 3.68681434 |
| 49 | cullin deneddylation (GO:0010388) | 3.68434825 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.68216436 |
| 51 | protein targeting to ER (GO:0045047) | 3.65127661 |
| 52 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.65113869 |
| 53 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.65113869 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.64407523 |
| 55 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.62546802 |
| 56 | hydrogen ion transmembrane transport (GO:1902600) | 3.61843588 |
| 57 | mitotic recombination (GO:0006312) | 3.61490723 |
| 58 | translational initiation (GO:0006413) | 3.61196250 |
| 59 | protein-cofactor linkage (GO:0018065) | 3.60373590 |
| 60 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.59267991 |
| 61 | CENP-A containing nucleosome assembly (GO:0034080) | 3.58396736 |
| 62 | protein deneddylation (GO:0000338) | 3.56153371 |
| 63 | termination of RNA polymerase III transcription (GO:0006386) | 3.54694632 |
| 64 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.54694632 |
| 65 | cytochrome complex assembly (GO:0017004) | 3.51716516 |
| 66 | protein localization to endoplasmic reticulum (GO:0070972) | 3.49644770 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.49114255 |
| 68 | telomere maintenance via telomere lengthening (GO:0010833) | 3.46714245 |
| 69 | chromatin remodeling at centromere (GO:0031055) | 3.44572831 |
| 70 | spliceosomal snRNP assembly (GO:0000387) | 3.44427684 |
| 71 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.44383753 |
| 72 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.43173305 |
| 73 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.43103265 |
| 74 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.43103265 |
| 75 | proton transport (GO:0015992) | 3.43024143 |
| 76 | 7-methylguanosine mRNA capping (GO:0006370) | 3.42468349 |
| 77 | translation (GO:0006412) | 3.42218387 |
| 78 | ribosome biogenesis (GO:0042254) | 3.41177069 |
| 79 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.39652948 |
| 80 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.39106837 |
| 81 | hydrogen transport (GO:0006818) | 3.38686826 |
| 82 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.38017756 |
| 83 | rRNA processing (GO:0006364) | 3.36952907 |
| 84 | 7-methylguanosine RNA capping (GO:0009452) | 3.36075756 |
| 85 | RNA capping (GO:0036260) | 3.36075756 |
| 86 | rRNA modification (GO:0000154) | 3.34351379 |
| 87 | behavioral response to nicotine (GO:0035095) | 3.33933244 |
| 88 | cellular protein complex disassembly (GO:0043624) | 3.30738692 |
| 89 | positive regulation of ligase activity (GO:0051351) | 3.29550474 |
| 90 | cell cycle G1/S phase transition (GO:0044843) | 3.29087796 |
| 91 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.29087796 |
| 92 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.28044181 |
| 93 | viral life cycle (GO:0019058) | 3.27271302 |
| 94 | rRNA metabolic process (GO:0016072) | 3.23191775 |
| 95 | pseudouridine synthesis (GO:0001522) | 3.21204689 |
| 96 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.19345818 |
| 97 | organelle disassembly (GO:1903008) | 3.17931515 |
| 98 | mitotic metaphase plate congression (GO:0007080) | 3.17661988 |
| 99 | ribosome assembly (GO:0042255) | 3.13552564 |
| 100 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.13455572 |
| 101 | signal peptide processing (GO:0006465) | 3.13413035 |
| 102 | * platelet dense granule organization (GO:0060155) | 3.12304369 |
| 103 | DNA damage response, detection of DNA damage (GO:0042769) | 3.12078642 |
| 104 | protein localization to cilium (GO:0061512) | 3.10853054 |
| 105 | kinetochore assembly (GO:0051382) | 3.10595914 |
| 106 | kinetochore organization (GO:0051383) | 3.10461654 |
| 107 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.10218807 |
| 108 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.10033203 |
| 109 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.07176253 |
| 110 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.05489057 |
| 111 | positive regulation of cell cycle arrest (GO:0071158) | 3.04187891 |
| 112 | cellular component biogenesis (GO:0044085) | 3.02638169 |
| 113 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.02152068 |
| 114 | establishment of integrated proviral latency (GO:0075713) | 3.01957918 |
| 115 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.01578836 |
| 116 | transcription from RNA polymerase I promoter (GO:0006360) | 2.99945097 |
| 117 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.99819199 |
| 118 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.99819199 |
| 119 | viral mRNA export from host cell nucleus (GO:0046784) | 2.96876808 |
| 120 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.96833785 |
| 121 | DNA replication-independent nucleosome organization (GO:0034724) | 2.96833785 |
| 122 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.95496494 |
| 123 | spliceosomal complex assembly (GO:0000245) | 2.94454777 |
| 124 | kynurenine metabolic process (GO:0070189) | 2.94139255 |
| 125 | termination of RNA polymerase I transcription (GO:0006363) | 2.92695998 |
| 126 | regulation of ligase activity (GO:0051340) | 2.92520478 |
| 127 | protein complex disassembly (GO:0043241) | 2.91416539 |
| 128 | DNA double-strand break processing (GO:0000729) | 2.90948838 |
| 129 | protein targeting to mitochondrion (GO:0006626) | 2.89801882 |
| 130 | establishment of protein localization to mitochondrion (GO:0072655) | 2.89375682 |
| 131 | protein localization to mitochondrion (GO:0070585) | 2.88007648 |
| 132 | ribonucleoprotein complex disassembly (GO:0032988) | 2.87442466 |
| 133 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.86854771 |
| 134 | mannosylation (GO:0097502) | 2.86564738 |
| 135 | negative regulation of mast cell activation (GO:0033004) | 2.86020932 |
| 136 | ATP biosynthetic process (GO:0006754) | 2.85778973 |
| 137 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.85405893 |
| 138 | negative regulation of membrane potential (GO:0045837) | 2.84091261 |
| 139 | L-methionine salvage (GO:0071267) | 2.84023670 |
| 140 | L-methionine biosynthetic process (GO:0071265) | 2.84023670 |
| 141 | amino acid salvage (GO:0043102) | 2.84023670 |
| 142 | protein localization to kinetochore (GO:0034501) | 2.83540015 |
| 143 | macromolecular complex disassembly (GO:0032984) | 2.82785331 |
| 144 | establishment of chromosome localization (GO:0051303) | 2.82439158 |
| 145 | intracellular protein transmembrane import (GO:0044743) | 2.82030178 |
| 146 | adenosine metabolic process (GO:0046085) | 2.81947407 |
| 147 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.81715477 |
| 148 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.81668296 |
| 149 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.81668296 |
| 150 | negative regulation of telomere maintenance (GO:0032205) | 2.78932581 |
| 151 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.76092885 |
| 152 | indole-containing compound catabolic process (GO:0042436) | 2.71148549 |
| 153 | indolalkylamine catabolic process (GO:0046218) | 2.71148549 |
| 154 | tryptophan catabolic process (GO:0006569) | 2.71148549 |
| 155 | C-terminal protein amino acid modification (GO:0018410) | 2.66156120 |
| 156 | C-terminal protein lipidation (GO:0006501) | 2.64534914 |
| 157 | GPI anchor metabolic process (GO:0006505) | 2.64487764 |
| 158 | tRNA processing (GO:0008033) | 2.63858117 |
| 159 | histone mRNA metabolic process (GO:0008334) | 2.62701483 |
| 160 | positive regulation of mitochondrial fission (GO:0090141) | 2.52648660 |
| 161 | mitochondrial transport (GO:0006839) | 2.51566992 |
| 162 | regulation of cellular amine metabolic process (GO:0033238) | 2.49939223 |
| 163 | aldehyde catabolic process (GO:0046185) | 2.48966148 |
| 164 | GPI anchor biosynthetic process (GO:0006506) | 2.48827179 |
| 165 | peptidyl-histidine modification (GO:0018202) | 2.46730957 |
| 166 | GTP biosynthetic process (GO:0006183) | 2.45420270 |
| 167 | oxidative phosphorylation (GO:0006119) | 2.44377905 |
| 168 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.42012163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.12365863 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.25609850 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.01143460 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.79408375 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.79097611 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.69166015 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.53072513 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.28125851 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.20259306 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.08193854 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.03282915 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.96844373 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.95741500 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.94658861 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.86237767 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.84889856 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.80986969 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.76556787 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.72663257 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.59976553 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.58891229 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.57776742 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.51655590 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.48918856 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.39712254 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.37511266 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.25614238 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24978885 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.23679279 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23083474 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.22770240 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21526584 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.20608050 |
| 34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.19509933 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.16857569 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.15446019 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14559232 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.10745434 |
| 39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.09101012 |
| 40 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.06665808 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 2.05049963 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03854211 |
| 43 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.99383843 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.97527688 |
| 45 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.97204252 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.96485309 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.92679174 |
| 48 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.91629628 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.89540838 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87886113 |
| 51 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.87368270 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83881311 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83618962 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83061131 |
| 55 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82975531 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81466173 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.75907677 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.71217848 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70728260 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.70726571 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70500491 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68718736 |
| 63 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61580039 |
| 64 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.58723554 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58457905 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58110779 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55430894 |
| 68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.55202686 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54869738 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53414053 |
| 71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.48810227 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47640613 |
| 73 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.45985721 |
| 74 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.45379751 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44561714 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.43845726 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.43845726 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41661977 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40821758 |
| 80 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40126144 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39105966 |
| 82 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37243435 |
| 83 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34423752 |
| 84 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33619731 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33597702 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31374005 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30094173 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29925180 |
| 89 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29853330 |
| 90 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29853330 |
| 91 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29693094 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27982004 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26046790 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25987478 |
| 95 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25178335 |
| 96 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23986699 |
| 97 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21792677 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21683593 |
| 99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20001672 |
| 100 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.18938301 |
| 101 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18785140 |
| 102 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18639705 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15085468 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14944452 |
| 105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14849383 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14810031 |
| 107 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12620751 |
| 108 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12620751 |
| 109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11641191 |
| 110 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11591914 |
| 111 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09705696 |
| 112 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08556455 |
| 113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08087627 |
| 114 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07387858 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06690605 |
| 116 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05427932 |
| 117 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.04867406 |
| 118 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04281331 |
| 119 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04122197 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03491609 |
| 121 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03356396 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03028283 |
| 123 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02803128 |
| 124 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01256008 |
| 125 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99897024 |
| 126 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99339838 |
| 127 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98876495 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98532368 |
| 129 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98200871 |
| 130 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.98180862 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97558732 |
| 132 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97158947 |
| 133 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97068552 |
| 134 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96781155 |
| 135 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96487878 |
| 136 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95700726 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95522563 |
| 138 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95321370 |
| 139 | JUN_21703547_ChIP-Seq_K562_Human | 0.95194696 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94492996 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94353723 |
| 142 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94031333 |
| 143 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93155489 |
| 144 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.92999339 |
| 145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92676323 |
| 146 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.92174654 |
| 147 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92023603 |
| 148 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91741816 |
| 149 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90915763 |
| 150 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90472085 |
| 151 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.90292620 |
| 152 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.90219617 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90022359 |
| 154 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89847355 |
| 155 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89007004 |
| 156 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88784302 |
| 157 | MYC_22102868_ChIP-Seq_BL_Human | 0.88361104 |
| 158 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87408629 |
| 159 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84697841 |
| 160 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.82785305 |
| 161 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.81596420 |
| 162 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.81424479 |
| 163 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.78267748 |
| 164 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.76509544 |
| 165 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.75742414 |
| 166 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.75689093 |
| 167 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.74510938 |
| 168 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.73714270 |
| 169 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.72598159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.30789061 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.27636280 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.06270206 |
| 4 | MP0003077_abnormal_cell_cycle | 3.76163939 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.70810267 |
| 6 | MP0008057_abnormal_DNA_replication | 3.39478454 |
| 7 | MP0008058_abnormal_DNA_repair | 3.26538703 |
| 8 | MP0008007_abnormal_cellular_replicative | 2.98269221 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.98110245 |
| 10 | MP0003880_abnormal_central_pattern | 2.78965111 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.69411600 |
| 12 | MP0003011_delayed_dark_adaptation | 2.65530701 |
| 13 | MP0008932_abnormal_embryonic_tissue | 2.48625283 |
| 14 | MP0003195_calcinosis | 2.36040604 |
| 15 | MP0002736_abnormal_nociception_after | 2.33831424 |
| 16 | MP0006072_abnormal_retinal_apoptosis | 2.30777267 |
| 17 | MP0002102_abnormal_ear_morphology | 2.30065656 |
| 18 | MP0003786_premature_aging | 2.22347537 |
| 19 | MP0009046_muscle_twitch | 2.22208974 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.18403771 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 2.08913546 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.05219100 |
| 23 | MP0003186_abnormal_redox_activity | 2.04673241 |
| 24 | MP0009745_abnormal_behavioral_response | 1.94212066 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.94032957 |
| 26 | MP0005253_abnormal_eye_physiology | 1.92847357 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.92607896 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.92166766 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.90942303 |
| 30 | MP0000490_abnormal_crypts_of | 1.88081077 |
| 31 | MP0009785_altered_susceptibility_to | 1.85255032 |
| 32 | MP0005671_abnormal_response_to | 1.84880457 |
| 33 | MP0001984_abnormal_olfaction | 1.83561396 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.79819544 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.78153154 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.75413572 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.75413572 |
| 38 | MP0002090_abnormal_vision | 1.75305987 |
| 39 | MP0002398_abnormal_bone_marrow | 1.74887850 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.74692263 |
| 41 | MP0000350_abnormal_cell_proliferation | 1.73266626 |
| 42 | MP0001853_heart_inflammation | 1.71136778 |
| 43 | MP0004142_abnormal_muscle_tone | 1.70706710 |
| 44 | MP0001486_abnormal_startle_reflex | 1.67786607 |
| 45 | MP0002272_abnormal_nervous_system | 1.66511362 |
| 46 | MP0002132_abnormal_respiratory_system | 1.65486528 |
| 47 | MP0002735_abnormal_chemical_nociception | 1.63155271 |
| 48 | MP0001730_embryonic_growth_arrest | 1.62270402 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.60383124 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.59698032 |
| 51 | MP0003718_maternal_effect | 1.58658454 |
| 52 | MP0000685_abnormal_immune_system | 1.58200006 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.57277028 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.55142923 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.53492302 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.53338033 |
| 57 | MP0001800_abnormal_humoral_immune | 1.51919203 |
| 58 | MP0000313_abnormal_cell_death | 1.51662588 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.51565405 |
| 60 | MP0004742_abnormal_vestibular_system | 1.51056455 |
| 61 | MP0002722_abnormal_immune_system | 1.51033651 |
| 62 | MP0001819_abnormal_immune_cell | 1.50583857 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.50527380 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.47896428 |
| 65 | MP0000858_altered_metastatic_potential | 1.47666893 |
| 66 | MP0000716_abnormal_immune_system | 1.46051626 |
| 67 | MP0002452_abnormal_antigen_presenting | 1.45785611 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.45526116 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.45256314 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.45047586 |
| 71 | MP0009764_decreased_sensitivity_to | 1.43788095 |
| 72 | MP0006082_CNS_inflammation | 1.43160335 |
| 73 | MP0002429_abnormal_blood_cell | 1.41902067 |
| 74 | MP0002064_seizures | 1.41576607 |
| 75 | MP0003123_paternal_imprinting | 1.41503960 |
| 76 | MP0008872_abnormal_physiological_respon | 1.41065507 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 1.40352223 |
| 78 | MP0002723_abnormal_immune_serum | 1.39402222 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.39369193 |
| 80 | MP0003787_abnormal_imprinting | 1.37313140 |
| 81 | MP0005000_abnormal_immune_tolerance | 1.34064884 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 1.33981516 |
| 83 | MP0003436_decreased_susceptibility_to | 1.33869671 |
| 84 | MP0005025_abnormal_response_to | 1.32093496 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 1.32017019 |
| 86 | MP0002572_abnormal_emotion/affect_behav | 1.31681488 |
| 87 | MP0000427_abnormal_hair_cycle | 1.29061196 |
| 88 | MP0001440_abnormal_grooming_behavior | 1.28527955 |
| 89 | MP0000703_abnormal_thymus_morphology | 1.27753311 |
| 90 | MP0010307_abnormal_tumor_latency | 1.26612670 |
| 91 | MP0002734_abnormal_mechanical_nocicepti | 1.25420012 |
| 92 | MP0005174_abnormal_tail_pigmentation | 1.25201741 |
| 93 | MP0004885_abnormal_endolymph | 1.24025499 |
| 94 | MP0006292_abnormal_olfactory_placode | 1.23028205 |
| 95 | MP0002405_respiratory_system_inflammati | 1.21438343 |
| 96 | MP0001501_abnormal_sleep_pattern | 1.21197140 |
| 97 | MP0001970_abnormal_pain_threshold | 1.21050040 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 1.20969633 |
| 99 | MP0001529_abnormal_vocalization | 1.20530644 |
| 100 | MP0000647_abnormal_sebaceous_gland | 1.18622130 |
| 101 | MP0002160_abnormal_reproductive_system | 1.16167921 |
| 102 | MP0000358_abnormal_cell_content/ | 1.16144456 |
| 103 | MP0005646_abnormal_pituitary_gland | 1.14920948 |
| 104 | MP0005423_abnormal_somatic_nervous | 1.14823464 |
| 105 | MP0005367_renal/urinary_system_phenotyp | 1.12124847 |
| 106 | MP0000516_abnormal_urinary_system | 1.12124847 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 1.10746988 |
| 108 | MP0002080_prenatal_lethality | 1.10116642 |
| 109 | MP0001697_abnormal_embryo_size | 1.09732213 |
| 110 | MP0002095_abnormal_skin_pigmentation | 1.09574193 |
| 111 | MP0000015_abnormal_ear_pigmentation | 1.08903520 |
| 112 | MP0003635_abnormal_synaptic_transmissio | 1.07676675 |
| 113 | MP0002419_abnormal_innate_immunity | 1.06874515 |
| 114 | MP0002067_abnormal_sensory_capabilities | 1.06058845 |
| 115 | MP0008995_early_reproductive_senescence | 1.05892305 |
| 116 | MP0002210_abnormal_sex_determination | 1.03491112 |
| 117 | MP0002063_abnormal_learning/memory/cond | 0.99912515 |
| 118 | MP0002733_abnormal_thermal_nociception | 0.98368479 |
| 119 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96637144 |
| 120 | MP0005387_immune_system_phenotype | 0.95400333 |
| 121 | MP0001790_abnormal_immune_system | 0.95400333 |
| 122 | MP0002751_abnormal_autonomic_nervous | 0.95029508 |
| 123 | MP0005380_embryogenesis_phenotype | 0.94128524 |
| 124 | MP0001672_abnormal_embryogenesis/_devel | 0.94128524 |
| 125 | MP0003122_maternal_imprinting | 0.93467432 |
| 126 | MP0003121_genomic_imprinting | 0.93082990 |
| 127 | MP0002163_abnormal_gland_morphology | 0.92905337 |
| 128 | MP0005195_abnormal_posterior_eye | 0.92050142 |
| 129 | MP0004924_abnormal_behavior | 0.91857103 |
| 130 | MP0005386_behavior/neurological_phenoty | 0.91857103 |
| 131 | MP0001145_abnormal_male_reproductive | 0.91193247 |
| 132 | MP0005085_abnormal_gallbladder_physiolo | 0.90182779 |
| 133 | MP0002229_neurodegeneration | 0.90002687 |
| 134 | MP0001324_abnormal_eye_pigmentation | 0.88570860 |
| 135 | MP0003315_abnormal_perineum_morphology | 0.88290518 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.87051818 |
| 137 | MP0002557_abnormal_social/conspecific_i | 0.86625168 |
| 138 | MP0001542_abnormal_bone_strength | 0.86601568 |
| 139 | MP0001919_abnormal_reproductive_system | 0.86463185 |
| 140 | MP0004215_abnormal_myocardial_fiber | 0.85037859 |
| 141 | MP0001929_abnormal_gametogenesis | 0.84325738 |
| 142 | MP0005389_reproductive_system_phenotype | 0.83625934 |
| 143 | MP0002928_abnormal_bile_duct | 0.81703620 |
| 144 | MP0004133_heterotaxia | 0.81480373 |
| 145 | MP0003984_embryonic_growth_retardation | 0.79658832 |
| 146 | MP0002876_abnormal_thyroid_physiology | 0.79544866 |
| 147 | MP0002752_abnormal_somatic_nervous | 0.78844370 |
| 148 | MP0002234_abnormal_pharynx_morphology | 0.78791555 |
| 149 | MP0000372_irregular_coat_pigmentation | 0.78304525 |
| 150 | MP0000465_gastrointestinal_hemorrhage | 0.76783263 |
| 151 | MP0002909_abnormal_adrenal_gland | 0.76520359 |
| 152 | MP0002938_white_spotting | 0.76358995 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.76155791 |
| 154 | MP0003866_abnormal_defecation | 0.75948639 |
| 155 | MP0008789_abnormal_olfactory_epithelium | 0.75550626 |
| 156 | MP0002088_abnormal_embryonic_growth/wei | 0.75257203 |
| 157 | MP0005384_cellular_phenotype | 0.74327744 |
| 158 | MP0010155_abnormal_intestine_physiology | 0.73764219 |
| 159 | MP0009697_abnormal_copulation | 0.73610284 |
| 160 | MP0004270_analgesia | 0.73025095 |
| 161 | MP0000343_altered_response_to | 0.72997396 |
| 162 | MP0003633_abnormal_nervous_system | 0.72876377 |
| 163 | MP0000653_abnormal_sex_gland | 0.72741296 |
| 164 | MP0001873_stomach_inflammation | 0.72279372 |
| 165 | MP0001764_abnormal_homeostasis | 0.71975606 |
| 166 | MP0002006_tumorigenesis | 0.71076219 |
| 167 | MP0002085_abnormal_embryonic_tissue | 0.70875418 |
| 168 | MP0008260_abnormal_autophagy | 0.70783859 |
| 169 | MP0005464_abnormal_platelet_physiology | 0.70529289 |
| 170 | MP0000681_abnormal_thyroid_gland | 0.70273382 |
| 171 | MP0001905_abnormal_dopamine_level | 0.67959819 |
| 172 | MP0002166_altered_tumor_susceptibility | 0.67324940 |
| 173 | MP0004147_increased_porphyrin_level | 0.66278053 |
| 174 | MP0005266_abnormal_metabolism | 0.66059532 |
| 175 | MP0001119_abnormal_female_reproductive | 0.63980489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 4.84284651 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 4.75338565 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.62489396 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 4.50421056 |
| 5 | Aplastic anemia (HP:0001915) | 4.03933254 |
| 6 | Abnormality of the anterior horn cell (HP:0006802) | 3.58635161 |
| 7 | Degeneration of anterior horn cells (HP:0002398) | 3.58635161 |
| 8 | Breast hypoplasia (HP:0003187) | 3.58620852 |
| 9 | Cerebral hypomyelination (HP:0006808) | 3.36593349 |
| 10 | Oral leukoplakia (HP:0002745) | 3.24006635 |
| 11 | Chromsome breakage (HP:0040012) | 3.20861878 |
| 12 | Pancreatic cysts (HP:0001737) | 3.20052023 |
| 13 | Macrocytic anemia (HP:0001972) | 3.13998732 |
| 14 | Rough bone trabeculation (HP:0100670) | 3.09560917 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.09016910 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.07392433 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.07392433 |
| 18 | 3-Methylglutaconic aciduria (HP:0003535) | 3.06386563 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 3.06126166 |
| 20 | Mitochondrial inheritance (HP:0001427) | 2.99985881 |
| 21 | Thrombocytosis (HP:0001894) | 2.99785998 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 2.99688387 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 2.99688387 |
| 24 | Pallor (HP:0000980) | 2.95352897 |
| 25 | Carpal bone hypoplasia (HP:0001498) | 2.92620223 |
| 26 | Cerebral edema (HP:0002181) | 2.92510663 |
| 27 | Type II lissencephaly (HP:0007260) | 2.86827194 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.83810668 |
| 29 | Exertional dyspnea (HP:0002875) | 2.82704052 |
| 30 | Acute necrotizing encephalopathy (HP:0006965) | 2.82465645 |
| 31 | 11 pairs of ribs (HP:0000878) | 2.82243737 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.79016498 |
| 33 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.77763851 |
| 34 | Increased CSF lactate (HP:0002490) | 2.76391632 |
| 35 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.75650233 |
| 36 | Optic disc pallor (HP:0000543) | 2.72666260 |
| 37 | Pancreatic fibrosis (HP:0100732) | 2.71879501 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.71730240 |
| 39 | Increased serum lactate (HP:0002151) | 2.71223586 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.69143068 |
| 41 | True hermaphroditism (HP:0010459) | 2.68079520 |
| 42 | Agnosia (HP:0010524) | 2.65020952 |
| 43 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.61219489 |
| 44 | Absent thumb (HP:0009777) | 2.60989470 |
| 45 | Poor head control (HP:0002421) | 2.59968903 |
| 46 | Hepatic necrosis (HP:0002605) | 2.57350893 |
| 47 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.55184721 |
| 48 | Abnormality of the preputium (HP:0100587) | 2.54964067 |
| 49 | Respiratory failure (HP:0002878) | 2.54643316 |
| 50 | Premature graying of hair (HP:0002216) | 2.54021479 |
| 51 | Colon cancer (HP:0003003) | 2.53891103 |
| 52 | Type 2 muscle fiber atrophy (HP:0003554) | 2.50383954 |
| 53 | Abnormality of glycolysis (HP:0004366) | 2.46788636 |
| 54 | Increased serum pyruvate (HP:0003542) | 2.46788636 |
| 55 | Methylmalonic acidemia (HP:0002912) | 2.45425643 |
| 56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.45293400 |
| 57 | IgM deficiency (HP:0002850) | 2.45180358 |
| 58 | Muscle fiber atrophy (HP:0100295) | 2.43349158 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42847787 |
| 60 | Patellar aplasia (HP:0006443) | 2.41043835 |
| 61 | Bone marrow hypocellularity (HP:0005528) | 2.40425524 |
| 62 | Gait imbalance (HP:0002141) | 2.39035134 |
| 63 | Mutism (HP:0002300) | 2.38454844 |
| 64 | Meckel diverticulum (HP:0002245) | 2.37740377 |
| 65 | Leukodystrophy (HP:0002415) | 2.36611642 |
| 66 | Pancytopenia (HP:0001876) | 2.36400821 |
| 67 | Nephrogenic diabetes insipidus (HP:0009806) | 2.35165519 |
| 68 | Abnormal trabecular bone morphology (HP:0100671) | 2.34651268 |
| 69 | Abolished electroretinogram (ERG) (HP:0000550) | 2.34517105 |
| 70 | Reduced antithrombin III activity (HP:0001976) | 2.32046692 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.31135427 |
| 72 | CNS demyelination (HP:0007305) | 2.29921611 |
| 73 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.29478504 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28369511 |
| 75 | Abnormality of alanine metabolism (HP:0010916) | 2.28369511 |
| 76 | Hyperalaninemia (HP:0003348) | 2.28369511 |
| 77 | Abnormality of the ileum (HP:0001549) | 2.28256422 |
| 78 | Abnormality of chromosome stability (HP:0003220) | 2.27186777 |
| 79 | Cellular immunodeficiency (HP:0005374) | 2.26273740 |
| 80 | Microretrognathia (HP:0000308) | 2.25719666 |
| 81 | Retinal dysplasia (HP:0007973) | 2.25063512 |
| 82 | Inability to walk (HP:0002540) | 2.23940268 |
| 83 | Myelodysplasia (HP:0002863) | 2.23900975 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 2.22789086 |
| 85 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.19490077 |
| 86 | Pulmonary fibrosis (HP:0002206) | 2.17943684 |
| 87 | Microvesicular hepatic steatosis (HP:0001414) | 2.17410253 |
| 88 | Postnatal microcephaly (HP:0005484) | 2.17324072 |
| 89 | Polyphagia (HP:0002591) | 2.15702063 |
| 90 | Progressive macrocephaly (HP:0004481) | 2.15031760 |
| 91 | Lymphoma (HP:0002665) | 2.14691649 |
| 92 | Tongue fasciculations (HP:0001308) | 2.13118023 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11651065 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11651065 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11651065 |
| 96 | Horseshoe kidney (HP:0000085) | 2.11114258 |
| 97 | Congenital stationary night blindness (HP:0007642) | 2.11069632 |
| 98 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.08315082 |
| 99 | Methylmalonic aciduria (HP:0012120) | 2.08145531 |
| 100 | Cleft eyelid (HP:0000625) | 2.07127129 |
| 101 | Lethargy (HP:0001254) | 2.06483655 |
| 102 | Hypothermia (HP:0002045) | 2.06106605 |
| 103 | Respiratory difficulties (HP:0002880) | 2.05546949 |
| 104 | Abnormality of the labia minora (HP:0012880) | 2.05395421 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04537386 |
| 106 | Constricted visual fields (HP:0001133) | 2.04154383 |
| 107 | Trismus (HP:0000211) | 2.03967158 |
| 108 | CNS hypomyelination (HP:0003429) | 2.03444589 |
| 109 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.03047245 |
| 110 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.03047245 |
| 111 | Abnormal protein glycosylation (HP:0012346) | 2.03047245 |
| 112 | Abnormal glycosylation (HP:0012345) | 2.03047245 |
| 113 | Duplicated collecting system (HP:0000081) | 2.01784676 |
| 114 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.01566498 |
| 115 | Febrile seizures (HP:0002373) | 1.99688021 |
| 116 | Acute encephalopathy (HP:0006846) | 1.99023498 |
| 117 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.98952608 |
| 118 | Renal Fanconi syndrome (HP:0001994) | 1.98026917 |
| 119 | Abnormality of the renal collecting system (HP:0004742) | 1.97891566 |
| 120 | IgG deficiency (HP:0004315) | 1.97771649 |
| 121 | Petechiae (HP:0000967) | 1.96893619 |
| 122 | Lissencephaly (HP:0001339) | 1.96863184 |
| 123 | Nephronophthisis (HP:0000090) | 1.96706363 |
| 124 | Abnormality of serum amino acid levels (HP:0003112) | 1.95046003 |
| 125 | Exercise intolerance (HP:0003546) | 1.94835303 |
| 126 | Amyotrophic lateral sclerosis (HP:0007354) | 1.94813274 |
| 127 | Asplenia (HP:0001746) | 1.93720841 |
| 128 | Secondary amenorrhea (HP:0000869) | 1.92691874 |
| 129 | Atonic seizures (HP:0010819) | 1.92591055 |
| 130 | Recurrent abscess formation (HP:0002722) | 1.92393414 |
| 131 | Sclerocornea (HP:0000647) | 1.92282305 |
| 132 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.92063403 |
| 133 | Neoplasm of the pancreas (HP:0002894) | 1.90196451 |
| 134 | Optic nerve coloboma (HP:0000588) | 1.89678140 |
| 135 | Irregular epiphyses (HP:0010582) | 1.88798810 |
| 136 | Parakeratosis (HP:0001036) | 1.87912532 |
| 137 | Lactic acidosis (HP:0003128) | 1.87841032 |
| 138 | X-linked dominant inheritance (HP:0001423) | 1.87771809 |
| 139 | Absent radius (HP:0003974) | 1.87751242 |
| 140 | Premature ovarian failure (HP:0008209) | 1.86567958 |
| 141 | Genital tract atresia (HP:0001827) | 1.85923127 |
| 142 | Prolonged neonatal jaundice (HP:0006579) | 1.83459827 |
| 143 | Stenosis of the external auditory canal (HP:0000402) | 1.82535855 |
| 144 | Renal cortical cysts (HP:0000803) | 1.82319426 |
| 145 | Pendular nystagmus (HP:0012043) | 1.81971212 |
| 146 | Neutropenia (HP:0001875) | 1.81967580 |
| 147 | Vaginal atresia (HP:0000148) | 1.81416484 |
| 148 | Dialeptic seizures (HP:0011146) | 1.77658440 |
| 149 | Vacuolated lymphocytes (HP:0001922) | 1.76422778 |
| 150 | Progressive inability to walk (HP:0002505) | 1.76171582 |
| 151 | Emotional lability (HP:0000712) | 1.74815021 |
| 152 | Increased muscle lipid content (HP:0009058) | 1.73219497 |
| 153 | Stomatitis (HP:0010280) | 1.72463046 |
| 154 | Bile duct proliferation (HP:0001408) | 1.72161407 |
| 155 | Abnormal biliary tract physiology (HP:0012439) | 1.72161407 |
| 156 | Blindness (HP:0000618) | 1.71165564 |
| 157 | Muscular hypotonia of the trunk (HP:0008936) | 1.70718594 |
| 158 | Abnormality of the renal cortex (HP:0011035) | 1.70713394 |
| 159 | Limb dystonia (HP:0002451) | 1.69298071 |
| 160 | Abnormality of the pons (HP:0007361) | 1.67639444 |
| 161 | Focal motor seizures (HP:0011153) | 1.67594130 |
| 162 | Nausea (HP:0002018) | 1.65093958 |
| 163 | Short tibia (HP:0005736) | 1.64298732 |
| 164 | Optic nerve hypoplasia (HP:0000609) | 1.63717303 |
| 165 | Hyperglycinemia (HP:0002154) | 1.62265259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.47172447 |
| 2 | EIF2AK1 | 3.74999431 |
| 3 | WEE1 | 3.38301262 |
| 4 | STK16 | 3.33182990 |
| 5 | TESK2 | 2.63424755 |
| 6 | WNK3 | 2.59177647 |
| 7 | MAP4K2 | 2.55937401 |
| 8 | BRSK2 | 2.53178046 |
| 9 | PIM2 | 2.45073050 |
| 10 | NME2 | 2.42204373 |
| 11 | SRPK1 | 2.37903714 |
| 12 | TRIM28 | 2.34271236 |
| 13 | EIF2AK3 | 2.33203877 |
| 14 | MAP3K12 | 2.21644911 |
| 15 | CDC7 | 2.07404034 |
| 16 | PINK1 | 2.06858153 |
| 17 | VRK1 | 1.94459337 |
| 18 | NUAK1 | 1.89957274 |
| 19 | ACVR1B | 1.84975935 |
| 20 | TESK1 | 1.83535099 |
| 21 | MAP2K7 | 1.82885053 |
| 22 | TSSK6 | 1.82697973 |
| 23 | CCNB1 | 1.82419600 |
| 24 | FRK | 1.80154646 |
| 25 | CASK | 1.73122301 |
| 26 | MAP3K4 | 1.71014136 |
| 27 | PLK4 | 1.70381620 |
| 28 | VRK2 | 1.65957029 |
| 29 | BRSK1 | 1.57172530 |
| 30 | GRK1 | 1.49922896 |
| 31 | LIMK1 | 1.43992016 |
| 32 | PLK1 | 1.42850790 |
| 33 | ARAF | 1.39707816 |
| 34 | PASK | 1.38916266 |
| 35 | TLK1 | 1.37914674 |
| 36 | SCYL2 | 1.37385355 |
| 37 | CSNK1G2 | 1.36687429 |
| 38 | PLK3 | 1.36113482 |
| 39 | INSRR | 1.33814593 |
| 40 | EPHA2 | 1.33641976 |
| 41 | MARK1 | 1.33137762 |
| 42 | DYRK3 | 1.31500565 |
| 43 | MAP4K1 | 1.30108681 |
| 44 | MKNK1 | 1.28983049 |
| 45 | RPS6KB2 | 1.26699861 |
| 46 | NEK2 | 1.25235051 |
| 47 | PBK | 1.23111576 |
| 48 | MST4 | 1.22341411 |
| 49 | CAMKK2 | 1.17494604 |
| 50 | NME1 | 1.16563228 |
| 51 | IRAK4 | 1.15777079 |
| 52 | ATR | 1.15429109 |
| 53 | CSNK1G1 | 1.15254102 |
| 54 | ZAK | 1.13588246 |
| 55 | SIK3 | 1.13437076 |
| 56 | AURKB | 1.12425569 |
| 57 | PRKCG | 1.06750921 |
| 58 | GRK7 | 1.05669065 |
| 59 | OXSR1 | 1.04511646 |
| 60 | AURKA | 1.04448032 |
| 61 | NEK1 | 1.03596008 |
| 62 | MAPK13 | 1.03446184 |
| 63 | CSNK1A1L | 1.00847501 |
| 64 | DYRK2 | 1.00839906 |
| 65 | BRAF | 1.00386746 |
| 66 | PIM1 | 0.99625063 |
| 67 | PRKCE | 0.99046686 |
| 68 | TAOK3 | 0.98848795 |
| 69 | PAK4 | 0.98418311 |
| 70 | TNIK | 0.97517339 |
| 71 | CDK19 | 0.97468289 |
| 72 | CDK7 | 0.96421735 |
| 73 | CHEK2 | 0.96052159 |
| 74 | TEC | 0.95823383 |
| 75 | MAP3K11 | 0.94833063 |
| 76 | DAPK2 | 0.93993489 |
| 77 | KIT | 0.92945060 |
| 78 | TAF1 | 0.92289098 |
| 79 | TTK | 0.90237082 |
| 80 | DAPK1 | 0.90179790 |
| 81 | RPS6KA4 | 0.90032442 |
| 82 | PLK2 | 0.90012128 |
| 83 | BLK | 0.88878853 |
| 84 | MAPKAPK3 | 0.88386548 |
| 85 | BCKDK | 0.82046599 |
| 86 | EIF2AK2 | 0.81704019 |
| 87 | CDK8 | 0.80054143 |
| 88 | MAP3K5 | 0.79914294 |
| 89 | MINK1 | 0.76877127 |
| 90 | ZAP70 | 0.75703072 |
| 91 | TGFBR1 | 0.74402336 |
| 92 | LRRK2 | 0.73589132 |
| 93 | MAP3K8 | 0.73092368 |
| 94 | MAP3K14 | 0.72882075 |
| 95 | IKBKB | 0.71780302 |
| 96 | KDR | 0.69463869 |
| 97 | BTK | 0.69065036 |
| 98 | STK4 | 0.68132246 |
| 99 | CSF1R | 0.68021739 |
| 100 | ERBB3 | 0.66696108 |
| 101 | MKNK2 | 0.66094189 |
| 102 | CSNK2A1 | 0.66054257 |
| 103 | BCR | 0.66041301 |
| 104 | TIE1 | 0.65604320 |
| 105 | CHEK1 | 0.65273413 |
| 106 | FLT3 | 0.63548567 |
| 107 | TXK | 0.63168385 |
| 108 | ADRBK1 | 0.62765377 |
| 109 | MARK3 | 0.62294833 |
| 110 | PAK3 | 0.61743368 |
| 111 | PDK2 | 0.61473280 |
| 112 | PRKCI | 0.61334217 |
| 113 | CSNK2A2 | 0.60494410 |
| 114 | ABL2 | 0.60491193 |
| 115 | SYK | 0.60044393 |
| 116 | MATK | 0.59881670 |
| 117 | CAMK2A | 0.59444425 |
| 118 | PAK1 | 0.59053522 |
| 119 | STK10 | 0.56281611 |
| 120 | CDK4 | 0.55850685 |
| 121 | ILK | 0.51435469 |
| 122 | MAP3K9 | 0.51379815 |
| 123 | RIPK4 | 0.50738863 |
| 124 | YES1 | 0.50567035 |
| 125 | LYN | 0.43843603 |
| 126 | CSNK1A1 | 0.42087406 |
| 127 | STK38L | 0.41728761 |
| 128 | CSNK1G3 | 0.40868130 |
| 129 | TAOK2 | 0.40827147 |
| 130 | BMPR1B | 0.40223439 |
| 131 | PRPF4B | 0.38705172 |
| 132 | ADRBK2 | 0.38375324 |
| 133 | EGFR | 0.37800279 |
| 134 | DAPK3 | 0.37256373 |
| 135 | RPS6KA5 | 0.37045332 |
| 136 | WNK4 | 0.36562679 |
| 137 | PKN1 | 0.36404147 |
| 138 | PRKACA | 0.35622271 |
| 139 | MAP2K6 | 0.35018576 |
| 140 | CDK2 | 0.34054604 |
| 141 | GRK6 | 0.33418043 |
| 142 | BMPR2 | 0.33075625 |
| 143 | ABL1 | 0.31607032 |
| 144 | PRKCQ | 0.31335376 |
| 145 | FGR | 0.29897603 |
| 146 | NTRK2 | 0.29754028 |
| 147 | GRK5 | 0.28253643 |
| 148 | PNCK | 0.28078042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.82503420 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.45396196 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 4.28818306 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.80374698 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.57680086 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.23829561 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.89577783 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.85802344 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.71665858 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.61664426 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.58385774 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.47888793 |
| 13 | Protein export_Homo sapiens_hsa03060 | 2.01528174 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.96451633 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.96116618 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.90358419 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.86032499 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80674699 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.76389355 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.74096267 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70328217 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70086102 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.69161799 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.63593738 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60675407 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.59037377 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.57082588 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53503252 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.48951921 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.48587774 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45128823 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.38313120 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.30286659 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27380554 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18901861 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10567880 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08930545 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06887861 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.05836753 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02662434 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01905949 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99403411 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98111337 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97996247 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91459836 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91238029 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88857552 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88636509 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86052748 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85894170 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85186185 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.84882115 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84789929 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84376340 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83812804 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.82820144 |
| 57 | Morphine addiction_Homo sapiens_hsa05032 | 0.81339370 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80897182 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80121986 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80068046 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80058049 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.79194076 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.77588839 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76893213 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.74308780 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72677712 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71982013 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71926837 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71737089 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66981570 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64587700 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64246437 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64070600 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63285537 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.62851602 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62782462 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62593806 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61636021 |
| 79 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60830138 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60775472 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59309051 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57586638 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56886456 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54703118 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54545022 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.52485707 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52212438 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.52196306 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50741122 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48918017 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47679076 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45415844 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44935255 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44405635 |
| 95 | Asthma_Homo sapiens_hsa05310 | 0.44388357 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43662189 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42971384 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42091728 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41824279 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41719688 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40925033 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.40696675 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40406203 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39810125 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38694186 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38288308 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38025245 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.38021865 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.37742700 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36232388 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36017818 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35359318 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35135418 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34488568 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34232650 |
| 116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33311641 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33000042 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32432212 |
| 119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32364727 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30032360 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.29687828 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28602844 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28484985 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27967589 |
| 125 | Hepatitis B_Homo sapiens_hsa05161 | 0.27089132 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27049927 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25393788 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.22846555 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22052965 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21869898 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21769263 |
| 132 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21193427 |
| 133 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.19874411 |
| 134 | Alcoholism_Homo sapiens_hsa05034 | 0.19288059 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.18922739 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.18693256 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18202430 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16075369 |
| 139 | Carbon metabolism_Homo sapiens_hsa01200 | 0.15649805 |
| 140 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.15109039 |
| 141 | Salmonella infection_Homo sapiens_hsa05132 | 0.14919533 |
| 142 | Tuberculosis_Homo sapiens_hsa05152 | 0.14570671 |
| 143 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.14150722 |
| 144 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13514734 |

